CARM1 methylates pyruvate kinase M2, which reversibly shifts the balance of metabolism from oxidative phosphorylation to aerobic glycolysis in BC cells, creating a metabolic vulnerability that can be therapeutically exploited (90). Here, CARM1 is linked to breast cancer.